Knight Therapeutics (TSE:GUD) Trading Up 0.2% – Time to Buy?

Knight Therapeutics Inc. (TSE:GUD)’s stock price was up 0.2% on Tuesday . The company traded as high as C$6.23 and last traded at C$6.15. Approximately 43,350 shares traded hands during mid-day trading, a decline of 55% from the average daily volume of 96,539 shares. The stock had previously closed at C$6.14.

Knight Therapeutics Price Performance

The company has a debt-to-equity ratio of 13.86, a current ratio of 2.62 and a quick ratio of 1.79. The business’s 50 day moving average price is C$6.08 and its 200 day moving average price is C$6.05. The stock has a market capitalization of C$610.63 million, a P/E ratio of -153.75, a price-to-earnings-growth ratio of -1,013.50 and a beta of 0.15.

Knight Therapeutics Company Profile

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company’s principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.